Biology of Blood and Marrow Transplantation
Volume 11, Issue 12 , Pages 943-944 , December 2005

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: Preface to the Series

  • Steven Pavletic, MD

      Affiliations

    • National Cancer Institute Bethesda, Maryland
  • ,
  • Georgia Vogelsang, MD

      Affiliations

    • Johns Hopkins University School of Medicine, Baltimore, Maryland

References 

  1. Shulman HM , Sullivan KM , Weiden PL , et al.   Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients . Am J Med . 1980;69:204–217
  2. Sullivan KM , Witherspoon RP , Storb R , et al.   Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease . Blood . 1988;72:555–561
  3. Lee SJ , Vogelsang G , Flowers ME . Chronic graft-versus-host disease . Biol Blood Marrow Transplant . 2003;9:215–233
  4. Vogelsang GB . How I treat chronic graft-versus-host disease . Blood . 2001;97:1196–1201
  5. Farag SS . Chronic graft-versus-host disease (where do we go from here?) . Bone Marrow Transplant . 2004;33:569–577

PII: S1083-8791(05)00677-4

doi: 10.1016/j.bbmt.2005.10.001

Biology of Blood and Marrow Transplantation
Volume 11, Issue 12 , Pages 943-944 , December 2005